Product Description
Prostamax, aka KEDP is a synthetic short-chain peptide bioregulator belonging to the Khavinson family of low-molecular-weight peptides studied for their tissue-associated regulatory activity. Investigations focus on its proposed mechanism as a signaling oligopeptide that interacts with chromatin and gene-promoter regions, where such peptides are hypothesized to modulate transcriptional activity and protein expression patterns within prostate-derived cell models.
Prostamax is a synthetic tetrapeptide bioregulator that targets cellular mechanisms related to chronic inflammation and DNA condensation processes in research models. Prostamax may demonstrate activity in prostate cell culture studies, offering researchers insights into bioregulatory pathways and cellular function modulation.
10MG VIAL